Foresite Capital Fund VI LP → IRulya Therapeutics Inc. QNCX

Stake: — Shares: — Class: Common Stock

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 2.67

59,944 shares short · +19.2% vs prior

Other 13D/G Filings on IRulya Therapeutics Inc.

Filed	Form	Filer	Stake	Shares
2026-06-10	SCHEDULE 13G	INTEGRATED CORE STRATEGIES (US) LLC	—	—	view →

Other Filings by Foresite Capital Fund VI LP

Filed	Form	Issuer	Stake	Shares
2026-08-17	SCHEDULE 13D	Latigo Biotherapeutics, Inc.	14.50%	2,203,800	view →
2026-08-17	SCHEDULE 13D	Latigo Biotherapeutics, Inc.	14.50%	2,203,800	view →
2026-04-03	SCHEDULE 13D/A	Alumis Inc. ALMS	12.70%	4,247,670	view →
2026-01-12	SCHEDULE	ALUMIS INC. ALMS	14.10%	16,189,804	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →